BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21112821)

  • 1. N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18(Ink4c) by the transforming mutant RET(C634R).
    Kulkarni MV; Franklin DS
    Mol Oncol; 2011 Feb; 5(1):24-35. PubMed ID: 21112821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
    Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
    Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
    van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Höppener JW
    Cancer Res; 2008 Mar; 68(5):1329-37. PubMed ID: 18316595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
    Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
    Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.
    Zindy F; Knoepfler PS; Xie S; Sherr CJ; Eisenman RN; Roussel MF
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11579-83. PubMed ID: 16864777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
    Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
    Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p27
    Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
    J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of RET with multiple endocrine neoplasia type 2.
    Zhang M; Liu Y; Fu J; Hu Y; Sun Z
    J Cancer Res Ther; 2017; 13(5):823-828. PubMed ID: 29237911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
    Lindberg D; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
    Georgitsi M
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
    Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
    Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.
    Bagheri-Yarmand R; Sinha KM; Gururaj AE; Ahmed Z; Rizvi YQ; Huang SC; Ladbury JE; Bogler O; Williams MD; Cote GJ; Gagel RF
    J Biol Chem; 2015 May; 290(18):11749-61. PubMed ID: 25795775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
    Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
    Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.
    Segouffin-Cariou C; Billaud M
    J Biol Chem; 2000 Feb; 275(5):3568-76. PubMed ID: 10652352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of cyclin-dependent kinase inhibitor p27 or p18 increases efficiency of iPSC generation without induction of iPSC genomic instability.
    Zhan Z; Song L; Zhang W; Gu H; Cheng H; Zhang Y; Yang Y; Ji G; Feng H; Cheng T; Li Y
    Cell Death Dis; 2019 Mar; 10(4):271. PubMed ID: 30894510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma.
    Cuccuru G; Lanzi C; Cassinelli G; Pratesi G; Tortoreto M; Petrangolini G; Seregni E; Martinetti A; Laccabue D; Zanchi C; Zunino F
    J Natl Cancer Inst; 2004 Jul; 96(13):1006-14. PubMed ID: 15240784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
    Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
    Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
    Iervolino A; Iuliano R; Trapasso F; Viglietto G; Melillo RM; Carlomagno F; Santoro M; Fusco A
    Cancer Res; 2006 Jun; 66(12):6280-7. PubMed ID: 16778204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
    Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
    Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.